Scottish Biotech Boosts its CAR-T Pipeline for Cancer and HIV – labiotech (press release) (blog)
|
Scottish Biotech Boosts its CAR–T Pipeline for Cancer and HIV
labiotech (press release) (blog) The Scottish biotech TC Biopharm will be working with its new partner Scotia Biologics on the development of CAR-T therapy candidates against neuroblastoma, breast cancer, prostate cancer, lymphoblastic leukemia and HIV. Scotia will develop several … Leading CAR–T Company Broadens Treatment Pipeline |
